Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into …

After the 1918 flu pandemic, the world is again facing a similar situation. However, the
advancement in medical science has made it possible to identify that the novel infectious …

Few human pathogens have been the focus of as much concentrated worldwide attention as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of COVID-19. Its …

The nucleocapsid (N) protein is an important antigen for coronavirus, which participate in
RNA package and virus particle release. In this study, we expressed the N protein of SARS …

Emerging and reemerging infectious diseases are global public concerns. With the outbreak
of unknown pneumonia in Wuhan, China in December 2019, a new coronavirus, SARS …

Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …

T cell immunity toward SARS-CoV-2 spike (S-), membrane (M-), and nucleocapsid (N-)
proteins may define COVID-19 severity. Therefore, we compare the SARS-CoV-2-reactive T …

With the worldwide spread of the novel severe acute respiratory syndrome coronavirus‐2
(SARS‐CoV‐2) resulting in declaration of a pandemic by the World Health Organization …

One of the key challenges of the recent COVID-19 pandemic is the ability to accurately
estimate the number of infected individuals, particularly asymptomatic and/or early-stage …

The huge RNA genome of SARS coronavirus comprises a number of open reading frames
that code for a total of eight accessory proteins. Although none of these are essential for …